Promoting Accountability, Transparency, Innovation, Efficiency, and Timeliness at FDA Act of 2012

This bill would streamline the Food and Drug Administration. The only clause relevant to Israel includes it on a list of countries whose citizens are given expanded privileges to investigate copyrighted devices.

1 cosponsor (1R)

Last major action: 4/17/12 referred to Senate Cmte. on Health, Education, Labor, and Pensions.